12:00 AM
 | 
Aug 22, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

NanoViricides preclinical data

In mice infected with HIV, HIVCide for 20 days reduced HIV viral load and protected CD4+ and CD8+ T cell...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >